Larimar Therapeutics Inc (LRMR): Trial met all primary objectives, demons...

Send PM Follow Ignore

Followers	0
Posts	182
Boards Moderated	0
Alias Born	07/20/2016

seppi08162

Re: None

Saturday, 06/23/2018 10:27:46 AM

Saturday, June 23, 2018 10:27:46 AM

Trial met all primary objectives, demonstrated efficacy and safety and established minimally effective dose of 0.9 mg for ZGN-1061

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent LRMR News

Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/09/2024 08:50:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:02:22 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:09:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:06:02 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 01:57:52 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2024 10:08:46 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 01:55:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 11:06:09 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/13/2024 09:46:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 12:03:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:33:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:32:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:31:40 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:31:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:08:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 06:51:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:31:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:00:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:05:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 11:03:03 AM
Larimar Therapeutics Shares Rise 10% After FDA Clears CTI-1601 Trial • Dow Jones News • 07/25/2023 05:06:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 11:02:05 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 08:15:06 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 08:13:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:08:34 PM

More LRMR News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover